Global IGY Polyclonal Antibodies Market Size, Status and Forecast 2020-2026
Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reaction to certain foreign substances, and specifically recognize them.
IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation process of IgY is also different from IgG. These biological features underlie IgY's competitive advantages over IgG. Shown in the four panels are several comparisons between IgY and IgG.
IgY is a hen egg polyclonal antibody. Hen eggs contain more than 450 separate antibodies and when consumed, are not rejected by the human immune system.
North America is the largest consumption place, with a consumption market share nearly 37.5% in 2017; Europe is the second largest consumption place with the consumption market share of 30% in 2017.
Market Analysis and Insights: Global IGY Polyclonal Antibodies Market
In 2019, the global IGY Polyclonal Antibodies market size was US$ 6 million and it is expected to reach US$ 14 million by the end of 2026, with a CAGR of 13.4% during 2021-2026.
Global IGY Polyclonal Antibodies Scope and Market Size
IGY Polyclonal Antibodies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global IGY Polyclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the IGY Polyclonal Antibodies market is segmented into Primary Antibody, Secondary Antibody, etc.
Segment by Application, the IGY Polyclonal Antibodies market is segmented into Academic Research, Commercial, etc.
Regional and Country-level Analysis
The IGY Polyclonal Antibodies market is analysed and market size information is provided by regions (countries).
The key regions covered in the IGY Polyclonal Antibodies market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
IGY Polyclonal Antibodies market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in IGY Polyclonal Antibodies business, the date to enter into the IGY Polyclonal Antibodies market, IGY Polyclonal Antibodies product introduction, recent developments, etc.
The major vendors include Merck, IGY Life Sciences, Abcam, Genway Biotech, Good Biotech, Gallus Immunotech, Creative Diagnostics, Agrisera, Innovagen AB, Capra Science, YO Proteins, GeneTex, etc.
This report focuses on the global IGY Polyclonal Antibodies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the IGY Polyclonal Antibodies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Merck
IGY Life Sciences
Abcam
Genway Biotech
Good Biotech
Gallus Immunotech
Creative Diagnostics
Agrisera
Innovagen AB
Capra Science
YO Proteins
GeneTex
Primary Antibody
Secondary Antibody
Academic Research
Commercial
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global IGY Polyclonal Antibodies status, future forecast, growth opportunity, key market and key players.
To present the IGY Polyclonal Antibodies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of IGY Polyclonal Antibodies are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation process of IgY is also different from IgG. These biological features underlie IgY's competitive advantages over IgG. Shown in the four panels are several comparisons between IgY and IgG.
IgY is a hen egg polyclonal antibody. Hen eggs contain more than 450 separate antibodies and when consumed, are not rejected by the human immune system.
North America is the largest consumption place, with a consumption market share nearly 37.5% in 2017; Europe is the second largest consumption place with the consumption market share of 30% in 2017.
Market Analysis and Insights: Global IGY Polyclonal Antibodies Market
In 2019, the global IGY Polyclonal Antibodies market size was US$ 6 million and it is expected to reach US$ 14 million by the end of 2026, with a CAGR of 13.4% during 2021-2026.
Global IGY Polyclonal Antibodies Scope and Market Size
IGY Polyclonal Antibodies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global IGY Polyclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the IGY Polyclonal Antibodies market is segmented into Primary Antibody, Secondary Antibody, etc.
Segment by Application, the IGY Polyclonal Antibodies market is segmented into Academic Research, Commercial, etc.
Regional and Country-level Analysis
The IGY Polyclonal Antibodies market is analysed and market size information is provided by regions (countries).
The key regions covered in the IGY Polyclonal Antibodies market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and IGY Polyclonal Antibodies Market Share AnalysisIGY Polyclonal Antibodies market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in IGY Polyclonal Antibodies business, the date to enter into the IGY Polyclonal Antibodies market, IGY Polyclonal Antibodies product introduction, recent developments, etc.
The major vendors include Merck, IGY Life Sciences, Abcam, Genway Biotech, Good Biotech, Gallus Immunotech, Creative Diagnostics, Agrisera, Innovagen AB, Capra Science, YO Proteins, GeneTex, etc.
This report focuses on the global IGY Polyclonal Antibodies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the IGY Polyclonal Antibodies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Merck
IGY Life Sciences
Abcam
Genway Biotech
Good Biotech
Gallus Immunotech
Creative Diagnostics
Agrisera
Innovagen AB
Capra Science
YO Proteins
GeneTex
Market segment by Type, the product can be split into
Primary Antibody
Secondary Antibody
Market segment by Application, split into
Academic Research
Commercial
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global IGY Polyclonal Antibodies status, future forecast, growth opportunity, key market and key players.
To present the IGY Polyclonal Antibodies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of IGY Polyclonal Antibodies are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
